George L Sing - Net Worth and Insider Trading

George L Sing Net Worth

The estimated net worth of George L Sing is at least $23 Million dollars as of 2024-11-13. George L Sing is the Director of Regeneron Pharmaceuticals Inc and owns about 28,499 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $23 Million. Details can be seen in George L Sing's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George L Sing has not made any transactions after 2024-02-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George L Sing

To

George L Sing Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George L Sing owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .

Click here to see the complete history of George L Sing’s form 4 insider trades.

Insider Ownership Summary of George L Sing

Ticker Comapny Transaction Date Type of Owner
REGN Regeneron Pharmaceuticals Inc 2024-02-26 director

George L Sing Latest Holdings Summary

George L Sing currently owns a total of 1 stock. George L Sing owns 28,499 shares of Regeneron Pharmaceuticals Inc (REGN) as of February 26, 2024, with a value of $23 Million.

Latest Holdings of George L Sing

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
REGN Regeneron Pharmaceuticals Inc 2024-02-26 28,499 821.00 23,397,679

Holding Weightings of George L Sing


George L Sing Form 4 Trading Tracker

According to the SEC Form 4 filings, George L Sing has made a total of 18 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 1,000 shares on February 26, 2024, which brought George L Sing around $992,500.

Insider Trading History of George L Sing

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George L Sing Trading Performance

GuruFocus tracks the stock performance after each of George L Sing's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George L Sing is 21.59%. GuruFocus also compares George L Sing's trading performance to market benchmark return within the same time period. The performance of stocks bought by George L Sing within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George L Sing's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George L Sing

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.36 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.81 LIMIT LIMIT LIMIT LIMIT LIMIT

George L Sing Ownership Network

Ownership Network List of George L Sing

No Data

Ownership Network Relation of George L Sing

Insider Network Chart

George L Sing Owned Company Details

What does Regeneron Pharmaceuticals Inc do?

Who are the key executives at Regeneron Pharmaceuticals Inc?

George L Sing is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .

Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary

Over the past 18 months, George L Sing made 3 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 5,500. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.

Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

George L Sing Mailing Address

Above is the net worth, insider trading, and ownership report for George L Sing. You might contact George L Sing via mailing address: Lancet Capital, 45 Rockefeller Plaza Ste 2008, New York Ny 10111.